Multi-layer spatial profiling reveals early response- associated immune remodeling after one cycle of neoadjuvant combination therapy in triple-negative breast cancer

Background Early identification of response to neoadjuvant therapy remains challenging in triple-negative breast cancer (TNBC), and conventional cell-density measurements may not fully capture treatment-induced changes in the spatial organisation of the tumour immune microenvironment. We investigated whether early spatial remodelling after a single treatment cycle was associated with subsequent pathological response. Methods This retrospective translational analysis used prospectively collected matched pre-treatment and post-cycle-1 core-needle biopsies from ten TNBC patients (five pCR and five non-pCR) enrolled in a clinical trial of neoadjuvant sintilimab, anlotinib and sequential chemotherapy. Six-colour multiplex immunofluorescence (CD8, CD20, CD68, FOXP3, PANCK and DAPI) was applied, and more than 1.7 million single cells were evaluated using a four-tier spatial framework comprising immune-cell density, tumour–immune spatial co-localisation, immune hotspot organisation and within-hotspot cellular interactions. Results After one treatment cycle, intratumoral and stromal CD8 + T-cell densities increased, whereas intratumoral CD68 + macrophages and stromal FOXP3 + regulatory T cells decreased. Tumour–CD20 + B-cell spatial co-localisation increased at the raw P-value level but did not survive FDR correction. The intratumoral immune hotspot score (Sintra/immune) decreased predominantly in patients who subsequently achieved pCR, and post-treatment values differed between pCR and non-pCR groups at the raw P-value level (P = 0.032; q = 0.064; exploratory ROC AUC = 0.92, 95% CI 0.66–1.00). Within immune hotspots, intratumoral CD68+–FOXP3 + interactions decreased and CD20+–CD8 + interactions increased across the cohort (both q < 0.05). Peritumoral CD20+–FOXP3 + interaction changes also differed between response groups (P = 0.032), although this association did not survive FDR correction. Conclusions These findings identify rapid spatial reorganisation of the TNBC immune microenvironment after a single treatment cycle and exploratory hotspot-level features associated with subsequent pathological response. Larger prospective cohorts are required for validation.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11231201/v1
Primary Topic
Breast Cancer Treatment Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Multi-layer spatial profiling reveals early response- associated immune remodeling after one cycle of neoadjuvant combination therapy in triple-negative breast cancer

Jiao-Mei Yuan, Fei Ji, Kun Wang
4 links
Research Square
Breast Cancer Treatment Studies
preprint

Multi-layer spatial profiling reveals early response- associated immune remodeling after one cycle of neoadjuvant combination therapy in triple-negative breast cancer

Jiao-Mei Yuan, Fei Ji, Kun Wang
preprint en

Abstract

Background Early identification of response to neoadjuvant therapy remains challenging in triple-negative breast cancer (TNBC), and conventional cell-density measurements may not fully capture treatment-induced changes in the spatial organisation of the tumour immune microenvironment. We investigated whether early spatial remodelling after a single treatment cycle was associated with subsequent pathological response. Methods This retrospective translational analysis used prospectively collected matched pre-treatment and post-cycle-1 core-needle biopsies from ten TNBC patients (five pCR and five non-pCR) enrolled in a clinical trial of neoadjuvant sintilimab, anlotinib and sequential chemotherapy. Six-colour multiplex immunofluorescence (CD8, CD20, CD68, FOXP3, PANCK and DAPI) was applied, and more than 1.7 million single cells were evaluated using a four-tier spatial framework comprising immune-cell density, tumour–immune spatial co-localisation, immune hotspot organisation and within-hotspot cellular interactions. Results After one treatment cycle, intratumoral and stromal CD8 + T-cell densities increased, whereas intratumoral CD68 + macrophages and stromal FOXP3 + regulatory T cells decreased. Tumour–CD20 + B-cell spatial co-localisation increased at the raw P-value level but did not survive FDR correction. The intratumoral immune hotspot score (Sintra/immune) decreased predominantly in patients who subsequently achieved pCR, and post-treatment values differed between pCR and non-pCR groups at the raw P-value level (P = 0.032; q = 0.064; exploratory ROC AUC = 0.92, 95% CI 0.66–1.00). Within immune hotspots, intratumoral CD68+–FOXP3 + interactions decreased and CD20+–CD8 + interactions increased across the cohort (both q < 0.05). Peritumoral CD20+–FOXP3 + interaction changes also differed between response groups (P = 0.032), although this association did not survive FDR correction. Conclusions These findings identify rapid spatial reorganisation of the TNBC immune microenvironment after a single treatment cycle and exploratory hotspot-level features associated with subsequent pathological response. Larger prospective cohorts are required for validation.

Research Square
Guangzhou University (CN), Guangdong Academy of Medical Sciences (CN), South China University of Technology (CN)
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon